Zheng G, Yan Z, Zou J, Zou X, Chai K, Zhang G
Front Oncol. 2025; 15:1520808.
PMID: 39963114
PMC: 11830605.
DOI: 10.3389/fonc.2025.1520808.
Dahl-Wilkie H, Gomez J, Kelley A, Manjit K, Mansoor B, Kanumuri P
Cells. 2025; 14(3).
PMID: 39936983
PMC: 11816438.
DOI: 10.3390/cells14030192.
Aidiel M, Abdul Mutalib M, Ramasamy R, Nik Ramli N, Tang S, Adam S
Molecules. 2025; 30(2).
PMID: 39860214
PMC: 11768088.
DOI: 10.3390/molecules30020346.
Zhou Y, Yao W, Chen S, Wang P, Fu J, Zhao J
Front Pharmacol. 2025; 15():1483186.
PMID: 39845793
PMC: 11753231.
DOI: 10.3389/fphar.2024.1483186.
Ishii K, Iguchi K, Matsuda C, Hirokawa Y, Sugimura Y, Watanabe M
J Clin Med. 2025; 13(24.
PMID: 39768760
PMC: 11678552.
DOI: 10.3390/jcm13247837.
CXCR1 Expression in MDA-PCa-2b Cell Upregulates ITM2A to Inhibit Tumor Growth.
Adekoya T, Smith N, Kothari P, Dacanay M, Li Y, Richardson R
Cancers (Basel). 2025; 16(24.
PMID: 39766038
PMC: 11674668.
DOI: 10.3390/cancers16244138.
Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2.
Celada S, Li G, Celada L, Kanagasabai T, Lu W, Brown L
Sci Signal. 2024; 17(867):eadk4122.
PMID: 39689183
PMC: 11784317.
DOI: 10.1126/scisignal.adk4122.
HSD3B1, prostate cancer mortality and modifiable outcomes.
Freitas P, Abdshah A, McKay R, Sharifi N
Nat Rev Urol. 2024; .
PMID: 39543357
DOI: 10.1038/s41585-024-00953-0.
piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: a step-toward ncRNA-precision.
Shaker F, Sanad E, Elghazaly H, Hsia S, Hamdy N
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):47-68.
PMID: 39102033
PMC: 11787197.
DOI: 10.1007/s00210-024-03308-z.
PiRNA-4447944 promotes castration-resistant growth and metastasis of prostate cancer by inhibiting NEFH expression through forming the piRNA-4447944-PIWIL2-NEFH complex.
Peng Q, Chen Y, Xie T, Pu D, Ho V, Sun J
Int J Biol Sci. 2024; 20(9):3638-3655.
PMID: 38993562
PMC: 11234203.
DOI: 10.7150/ijbs.96173.
Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities.
Elemam N, Hotait H, Saleh M, El-Huneidi W, Talaat I
Front Endocrinol (Lausanne). 2024; 15:1396192.
PMID: 38872970
PMC: 11169579.
DOI: 10.3389/fendo.2024.1396192.
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Redmer T, Raigel M, Sternberg C, Ziegler R, Probst C, Lindner D
Mol Cancer. 2024; 23(1):114.
PMID: 38811984
PMC: 11134959.
DOI: 10.1186/s12943-024-02022-x.
The RNA secondary structure of androgen receptor-FL and V7 transcripts reveals novel regulatory regions.
Rouse W, Tompkins V, OLeary C, Moss W
Nucleic Acids Res. 2024; 52(11):6596-6613.
PMID: 38554103
PMC: 11194067.
DOI: 10.1093/nar/gkae220.
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers.
Guzman J, Weigelt K, Neumann A, Tripal P, Schmid B, Winter Z
BMC Cancer. 2024; 24(1):346.
PMID: 38500100
PMC: 10949640.
DOI: 10.1186/s12885-024-12110-2.
Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT.
Kuo Y, Huo C, Li C, Chuu C
Cancer Gene Ther. 2024; 31(6):807-815.
PMID: 38480977
DOI: 10.1038/s41417-024-00753-z.
Incidence of Prostate Cancer in Transgender Women Undergoing Androgen Deprivation Therapy: A Review.
Tyagi S, Tyagi S
Indian J Endocrinol Metab. 2024; 27(6):476-479.
PMID: 38371191
PMC: 10871014.
DOI: 10.4103/ijem.ijem_53_23.
USP54 is a potential therapeutic target in castration-resistant prostate cancer.
Zhou C, Zhang X, Ma H, Zhou Y, Meng Y, Chen C
BMC Urol. 2024; 24(1):32.
PMID: 38321455
PMC: 10845770.
DOI: 10.1186/s12894-024-01418-7.
Arsenic-induced prostate cancer: an enigma.
Mukherjee A, Gopalakrishnan A
Med Oncol. 2024; 41(2):50.
PMID: 38184511
DOI: 10.1007/s12032-023-02266-5.
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide.
Matsuoka T, Sugiyama A, Miyawaki Y, Hidaka Y, Okuno Y, Sakai H
Cancer Sci. 2023; 115(1):283-297.
PMID: 37923364
PMC: 10823279.
DOI: 10.1111/cas.15984.
Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.
Camilo V, Pacheco M, Moreira-Silva F, Outeiro-Pinho G, Gaspar V, Mano J
Biomolecules. 2023; 13(10).
PMID: 37892208
PMC: 10605369.
DOI: 10.3390/biom13101526.